Home > Healthcare > Biotechnology > Biopharma > Cancer Stem Cells Therapy Market

Cancer Stem Cells Therapy Market Share

Report ID: GMI7152
Published Date: Oct 2023
Report Format: PDF

Download Free Sample

Cancer stem cells therapy Market Share

The key players operating in this market have established themselves through, continuous research & development, and a strong market presence. Gamida Cells, AbbVie Inc, and Astellas Pharma Inc account significant market share. These prominent players thrive through a combination of strategic approaches, diverse product portfolio, research and development initiatives, market understanding, and regulatory compliance.

Market players operating in the cancer stem cells therapy is as mentioned below:

Gamida Cells
AbbVie Inc
Astellas Pharma Inc
Novadip Biosciences
ReNeuron Group plc
Celyad
Adna GmBH
Thermo Fisher Scientific
Genentech Inc
Merck KGaA

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Global market for cancer stem cells therapy was worth USD 4.4 billion in revenue in 2022 and may record USD 12 billion by end of 2032 due to the increasing cases of cancer along with the growing private and public initiatives

The breast type cancer segment accounted for 24.4% of the market share in 2022 propelled by the increased funding and public awareness

North America industry size is expected to grow at 10% CAGR from 2023-2032 owing to presence of exceptionally advanced healthcare infrastructure, featuring state-of-the-art hospitals, research institutions, and biotechnology companies

Gamida Cells, AbbVie Inc, Astellas Pharma Inc, Novadip Biosciences, ReNeuron Group plc, Celyad, Adna GmBH, Thermo Fisher Scientific, Genentech Inc, and Merck KGaA are some of the major cancer stem cells therapy firms